Andrew J Murphy Regeneron Pharmaceuticals, Inc. (REGN) insider trading activity
Andrew J Murphy is EVP Research of REGENERON PHARMACEUTICALS, INC.. Currently has a direct ownership of 47,833 shares of REGN, which is worth approximately $33.2 Million. The most recent transaction as insider was on Aug 16, 2021, when has been sold 1,645 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
47.8K
2.53%
3M change
2.53%
12M change
Total Value Held
$33.2 Million
ANDREW J MURPHY Transaction History
AJM
Andrew J Murphy
EVP Research
Tarrytown, NY